Julia Wiedmeier is an Oncology physician affiliated with Mayo Clinic in Arizona. OpenAlex indexes 63 publications with 367 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13400 E Shea Blvd
Scottsdale, AZ 852595452
Telephone
480-301-8000Provider last certified this registry record 3 Sept 2020.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- Janssen Biotech, Inc.Program year20241 payment
- Genmab U.S., Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
68.5%CD38-directed Cytolytic Antibody25.4%Daratumumab100%Part B, office-administered≥54 patientsPD-1 inhibitor18.6%Pembrolizumab100%Part B, office-administered≥30 patients+ 7 more classes in this area
Metabolism & gastrointestinal
18.9%Other antiemetics15.1%Fosaprepitant100%Part B, office-administered≥41 patientsSerotonin-3 Receptor Antagonist3.6%Palonosetron hcl56%Ondansetron hydrochloride43%Ondansetron Hcl1%Part D + Part B≥86 patients+ 2 more classes in this area
Musculoskeletal
7%RANK Ligand Inhibitor6.9%Denosumab100%Part B, office-administered≥32 patientsBisphosphonate0.1%Zoledronic acid100%Part B, office-administered≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Caselli, MD
Mayo Clinic in Arizona
Mark Pittelkow, MD
Mayo Clinic in Arizona
John Dibaise, MD
Mayo Clinic in Arizona
Norio Fukami, MD
Mayo Clinic in Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”